Add BrightSurf on Google Email

Finding could lead to new approach for treating severe heart disease

A new study by UCSF researchers found that delivering the VEGF growth factor into mice with coronary heart disease prompted the growth of blood vessels in damaged heart tissue without causing side effects. This approach could lead to a treatment strategy for severe coronary heart disease that has been met with setbacks.

SourceUniversity of California - San Francisco·JournalProceedings of the National Academy of Sciences·DateDec 3, 2000

First gene therapy to calm pigs' out-of-sync hearts

Scientists at Johns Hopkins Medicine have developed a gene therapy that effectively treats abnormal rhythms in pig hearts, using genes delivered by routine catheter methods. The treatment showed a 20% decrease in heart rate compared to control animals, and has the potential to be transferred to human heart disease.

SourceJohns Hopkins Medicine·JournalNature Medicine·DateNov 30, 2000

Weizmann Institute scientists develop a novel system for analyzing genetic data that mimics the human capacity for unsupervised learning

The team designed a unique mathematical system for analyzing genetic data based on a computer algorithm that clusters information into relevant categories. The algorithm mimics unassisted learning, categorizing tissue samples into separate clusters according to their gene expression profiles.

SourceAmerican Committee for the Weizmann Institute of Science·JournalProceedings of the National Academy of Sciences·DateOct 15, 2000

Inheritable gene modification research should not proceed on humans without standards and oversight, AAAS report says

The American Association for the Advancement of Science recommends that human trials of inheritable genetic changes should not be initiated until reliable techniques for gene correction or replacement are developed. Serious ethical and religious issues also must be addressed as research policy is formulated, including concerns about ju...

In initial gene therapy trial, Jefferson scientists report successful gene transfer in Canavan disease

Researchers at Jefferson Medical College successfully introduced a therapeutic gene into the brain of two children with Canavan disease, showing decreased NAA concentration and increased myelin. The gene transfer demonstrated positive neurological improvements in the patients, offering hope for future use of gene therapy for brain dise...

SourceThomas Jefferson University·JournalAnnals of Neurology·DateJul 30, 2000

Study shows receptor molecule facilitates introduction of corrected genes into cells

University of North Carolina at Chapel Hill scientists have discovered a receptor molecule that can facilitate the introduction of corrected genes into cell nuclei, paving the way for potential gene therapy treatments. The study uses a G-protein-coupled receptor to enable weakened viruses to enter cells, carrying therapeutic payloads.

SourceUniversity of North Carolina at Chapel Hill·JournalNature Biotechnology·DateMay 28, 2000

UI researchers: step made in developing gene therapy to treat cystic fibrosis

A team of UI researchers has advanced understanding of how gene therapy might effectively treat cystic fibrosis by addressing two fundamental problems: inefficient gene transfer and lack of gene persistence. They demonstrated efficient and lasting gene transfer into airway cells using a new vector from the retrovirus family, feline imm...

SourceUniversity of Iowa·JournalJournal of Clinical Investigation·DateNov 29, 1999

Fluorescent signaling by immune cells

Researchers have successfully engineered CD4+ T cells to carry a fluorescent marker, allowing for the first time the tracking of autoimmune cells in vivo. The technique enables the study of physiological processes and inflammatory diseases, opening new avenues for therapeutic approaches.

SourceMax-Planck-Gesellschaft·JournalNature Medicine·DateSep 15, 1999

NIEHS-cloned gene linked to a natural substance that reduces vascular inflammation, a key to arterial clogging

Scientists have discovered that naturally occurring fatty acids can help prevent vascular inflammation, a key component in the development of atherosclerosis. The NIEHS-cloned gene produces an enzyme that makes these fatty acids, which can suppress inflammation and protect against heart disease.

Modifying plant genes without foreign DNA

Researchers at Cornell University's Boyce Thompson Institute have developed a novel approach to genetically modifying plants by using chimeraplasty, a method that coats gold particles with short chimeric DNA/RNA molecules. This technique has the potential to improve crop yields and nutritional value without involving foreign DNA.

SourceCornell University·JournalProceedings of the National Academy of Sciences·DateJul 21, 1999

Researchers Make Breakthrough In Gene Transfer

Researchers at Washington University School of Medicine have created a way to create harmless vectors from harmful viruses. They showed that the vectors are efficient couriers of genes and can be used to study gene regulation and functions, as well as deliver DNA vaccines.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateOct 27, 1998

Plants - Factories Of The Future

Researchers have identified genes that enable plants to produce epoxy and acetylenic fatty acids, key components in the production of polymers and specialty chemicals. This breakthrough could lead to the development of new, high-value products from plant-based raw materials.

SourceCSIRO Australia·JournalScience·DateMay 18, 1998

Jellyfish Help To Make Sugar Smarter

Researchers are utilizing a jellyfish gene to develop more efficient methods for inserting desirable genes into sugarcane plants. The gene, known as green fluorescent protein (GFP), allows scientists to quickly identify the effectiveness of genetic modifications.

Pitt Researchers Construct Novel Delivery System For Gene Therapy Of Liver Disorders

Researchers at the University of Pittsburgh have constructed a novel delivery system for gene therapy of liver disorders, using a reconstituted chylomicron remnant (RCR) that can safely transport genes to target cells. The system has resulted in extended production of therapeutic proteins in animal models.

SourceUniversity of Pittsburgh Medical Center·JournalProceedings of the National Academy of Sciences·DateDec 22, 1997

Failing Heart Cells Revived With Gene Therapy

Researchers at Duke University Medical Center have successfully revived flagging heart cells in laboratory vials using gene therapy. The treatment, which targets a protein kinase involved in heart muscle contraction, shows promise as a potential new drug target for treating congestive heart failure.

SourceDuke University Medical Center·JournalProceedings of the National Academy of Sciences·DateOct 22, 1997

Scientists Develop Powerful Tool For Studying TB

Researchers have created an efficient method to study Mycobacterium tuberculosis (TB) using transposon mutagenesis, allowing them to examine the effect of individual gene mutations on the bacteria's ability to grow or cause disease. This breakthrough enables the development of new drug targets and potential vaccine candidates.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalProceedings of the National Academy of Sciences·DateSep 29, 1997

Gene Marker Aids Livestock Production

Researchers have identified a genetic marker linked to the callipyge trait, which results in larger buttocks and leaner, less expensive meat. The discovery of the marker will aid efforts to breed sheep with heftier hindquarters using a blood test, and may also be applied to other species.